Vancity Investment Management’s Edwards Lifesciences EW Stock Holding History

Vancity Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.6M	Buy	144,995 +33,333	+30%	+$2.75M	1.84%	24
2025 Q4	$9.52M	Sell	111,662 -6,371	-5%	-$523K	1.29%	26
2025 Q3	$9.18M	Sell	118,033 -5,460	-4%	-$427K	1.22%	29
2025 Q2	$9.66M	Sell	123,493 -5,736	-4%	-$428K	1.22%	27
2025 Q1	$9.37M	Buy	+129,229	New	+$9.25M	1.28%	26
2024 Q3	$9.22M	Sell	139,763 -138,869	-50%	-$10.1M	1.11%	29
2024 Q2	$24.2M	Buy	278,632 +136,511	+96%	+$12.1M	1.53%	26
2024 Q1	$13.6M	Buy	142,121 +104,047	+273%	+$8.74M	1.62%	23
2023 Q4	$2.9M	Sell	38,074 -68,527	-64%	-$4.77M	0.43%	42
2023 Q3	$7.38M	Buy	+106,601	New	+$8.57M	0.96%	39

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vancity Investment Management's EW Position: Q1 2026 in Review

Vancity Investment Management increased its Edwards Lifesciences (EW) stake by 30% in Q1 2026, buying an estimated $2.75M and bringing the position to 144,995 shares worth $11.6M. The position accounts for 1.84% of the portfolio, ranked #24.

Vancity Investment Management first reported a position in EW in Q3 2023 and has held it in 10 quarters since. The position peaked at $24.2M in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Vancity Investment Management held 144,995 shares of Edwards Lifesciences worth $11.6M as of Q1 2026.
Vancity Investment Management bought 33,333 Edwards Lifesciences shares in Q1 2026, an estimated $2.75M.
Edwards Lifesciences made up 1.84% of Vancity Investment Management's portfolio in Q1 2026, its #24 holding.
Vancity Investment Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 10 quarters since.
Vancity Investment Management's Edwards Lifesciences position peaked at $24.2M in Q2 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Vancity Investment Management's 13F filing for Q1 2026, filed 15 May 2026.